CGTX ▲ +2.4% - Cognition Therapeutics, Inc. $CGTX - Cognition Therapeutics Announces Issuance of Composition of Matter Patent, Extending Protection for Zervimesine (CT1812) Through 2045 13-OCT-2026 06:00 AM ET